Rudinger, In “Peptide Hormones” (ed. J.A. Parsons) University Park Press, Baltimore, pp. 1-7, 1976.* |
Koff et al. , “Negative Regulation of G1 in Mammalian Cells Inhibition of Cyclin E-Dependent Kinase by TGF-β”, Science, 260: 536-539 (Apr. 23, 1993). |
Akama et al., “Genetic Status and Expression of the Cyclin-dependent Kinase Inhibitors in Human Gastric Carcinoma Cell Lines”, Jpn. J. Cancer Res., 87(8): 824-830 (1996). |
Akiyama et al., “G1 Phase Accumulation Induced by UCN-01 is Associated with Dephoshorylation of Rb and CDK2 Proteins as well as Induction of CDK Inhibitor p21/Cip1/WAF/1Sdi1 in p53-mutated Human Epidermoid Carcinoma A431 Cells”, Cancer Res., 57(8): 1495-1501 (1997). |
Deng et al., “A Novel Expression Vector for High-Level Synthesis and Secretion of Foreign Proteins in Escherichia Coli: Overproduction of Bovine Pancreatic Phospholipase A2”, Gene, 93: 229-234 (1990). |
Firpo et al., “Inactivation of a Cdk2 Inhibitor During Interleukin 2-induced Proliferation of Human T Lymphocytes”, Mol. Cell. Biol., 14: 4889-4901 (1994). |
Harper et al., “The p21 Cdk-interacting Protein Cip1 is a Protein Inhibitor of G1 Cyclin-dependent Kinases”, Cell, 75:805-816 (1993). |
Harvat et al., “The Role of p27kip1 in Gamma Interferon-mediated Growth Arrest of Mammary Epithelial Cells and Related Defects in Mammary Carcinoma Cells”, Oncogene, 14(17): 2111-2122 (1997). |
Hengst and Reed, “Translational Control of p27kip1 Accumulation During the Cell Cycle”, Science, 271(5257): 1861-1864 (1996). |
Koff et al., “Formation and Activation of a Cyclin E-cdk2 Complex During the G1 Phase of the Human Cell Cycle”, Science, 257: 1689-1694 (1992). |
Lloyd et al., “Aberrant p27kip1 Expression in Endocrine and Other Tumors”, Am. J. Pathol., 150(2): 401-407 (1997). |
Loda, et al., “Increased Proteasome-dependent Degradation of the Cyclin-dependent Kinase Inhibitor p27 in Aggressive Colorectal Carcinomas”, Nat. Med., 3(2): 231-234 (1997). |
Medin et al., “Efficient, Low-cost Protein Factories: Expression of Human Adenosine Deaminase in Baculovirus-infected Insect Larvae”, PNAS USA, 87: 2760-2764 (1990). |
Morosetti et al., “Alterations of the p27KIP1 Gene in Non-Hodgkin's Lymphomas and Adult T-cell Leukemia/Lymphoma”, Blood, 86(5): 1924-1930 (1995). |
Polyak et al., “Cloning of p27kip1, a Cyclin-dependent Kinase Inhibitor and a Potential Mediator of Extracellular Antimitogenic Signals”, Cell, 78: 59-63 (1994). |
Polyak et al., “p27kip1, a Cyclin-Cdk Inhibitor, Links Transforming Growth Factor-β and Contact Inhibition to Cell Cycle Arrest”, Genes & Dev., 8:9-22 (1994). |
Rivard et al., “Abrogation of p27kip1 by cDNA Antisense Suppresses Quiescence (G0 State) in Fibroblasts”, J. Biol. Chem., 271(31): 18337-18241 (1996). |
St. Croix et al., “Impact of the Cyclin-dependent Kinase Inhibitor p27kip1 on Resistance Tumor Cells to Anticancer Agents”, Nat. Med. 2(11): 1204-1210 (1996). |
Soos et al., “Formation of p27-CDK Complexes During the Human Mitotic Cell Cycle”, Cell Growth Differ., 7(2): 135-146 (1996). |
Tempst al., “Internal Sequence Analysis of Proteins Separated on Polyacrylamide Gels at the Submicrogram Level: Improved Methods, Applications and Gene Cloning Strategies”, Electrophoresis, 11: 37-553 (1990). |
Toyoshima and Hunter, “p27, A Novel Inhibitor of G1 Cyclin-CdK Protein Kinase Activity, is Related to p21”, Cell, 78:67-74 (1994). |
Van Dyke et al., “Single-step Purification of Bacterially Expressed Polypeptides Containing an Oligo-histidine Domain” Gene, 111 99-104 (1992). |